Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Mitigation of Emergence Agitation Through Implementation of Masimo Bridge Therapy

NCT06387953 is registered in ClinicalTrials.gov with University of Washington as lead sponsor.

NCT NCT06387953
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06387953 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Mitigation of Emergence Agitation Through Implementation of Masimo Bridge Therapy
Lead sponsor
University of Washington
Phase
Not applicable
Overall status
Withdrawn
Start date
August 27, 2024
Completion date
August 27, 2024
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

agitation, emergence, emergence delirium